Ignite Creation Date:
2024-05-05 @ 9:05 PM
Last Modification Date:
2024-10-26 @ 9:58 AM
Study NCT ID:
NCT00801515
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2011-07-25
First Post:
2008-12-02
Brief Title:
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Study Overview
Official Title:
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
Status:
NO_LONGER_AVAILABLE
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit Assessments of safety and tolerability of maraviroc when added to OBT will be continued
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None